<DOC>
	<DOC>NCT00443417</DOC>
	<brief_summary>The purpose of this study is to find optimistic dose and to evaluate the efficacy and safety of SK-PC-B70M in patients with mild to moderate Alzheimer's disease.</brief_summary>
	<brief_title>A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Age range : 50 ~ 85 years Clinical diagnosis of probable Alzheimer's disease (DSMIV and NINCDSADRDA criteria) MRI within the last 12 months consistent with a diagnosis of AD MMSE score 10 to 26 AChEI or memantine was discontinued at least 3 months prior to screening Patient in mild cognitive impairment (MCI; CDRSB &lt;2.5) Other central nervous disease hypothyroidism, Vitamin B12/ Folic acid deficiency, hypercalcemia, neurosyphilis, AIDS T.I.A or Major infarction within the last 12 months Any serious disorder that could limit the ability of the patient to participate in the study COPD or asthma Any condition which would make the patient or the caregiver, in the opinion of the investigator, unsuitable for the study</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>